Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation

Rheumatoid arthritis is a chronic inflammatory autoimmune disease, causing articular and extra-articular dysfunctions among patients, and it could result in irreversible joint damages or disability if untreated. A traditional Chinese medicine formula, Huayu-Qiangshen-Tongbi (HT) formula, has been ob...

Full description

Bibliographic Details
Main Authors: Zihao Wang, Ke-Gang Linghu, Yuanjia Hu, Huali Zuo, Hao Yi, Shi-Hang Xiong, Jinjian Lu, Ging Chan, Hua Yu, Run-Yue Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01065/full
_version_ 1818179552671694848
author Zihao Wang
Ke-Gang Linghu
Yuanjia Hu
Huali Zuo
Hao Yi
Shi-Hang Xiong
Jinjian Lu
Ging Chan
Hua Yu
Hua Yu
Hua Yu
Run-Yue Huang
Run-Yue Huang
author_facet Zihao Wang
Ke-Gang Linghu
Yuanjia Hu
Huali Zuo
Hao Yi
Shi-Hang Xiong
Jinjian Lu
Ging Chan
Hua Yu
Hua Yu
Hua Yu
Run-Yue Huang
Run-Yue Huang
author_sort Zihao Wang
collection DOAJ
description Rheumatoid arthritis is a chronic inflammatory autoimmune disease, causing articular and extra-articular dysfunctions among patients, and it could result in irreversible joint damages or disability if untreated. A traditional Chinese medicine formula, Huayu-Qiangshen-Tongbi (HT) formula, has been observed successful in controlling rheumatoid arthritis progression in traditional Chinese medicine clinics. In this study, we conducted a systematic analysis of the HT formula with a purpose of proposing for its potential mechanism of action using network pharmacological methods. The potential targets of the formula were collected and screened according to the topological features of their protein–protein interaction network, and we subsequently validated our prediction results through in vitro experiments. We proposed that the HT formula could interfere with the bone metabolism and the inflammatory pathways of the body. The experimental validation results indicated that HT formula could exhibit anti-inflammatory effects by regulating several signaling pathways specifically the Toll-like receptor signaling pathway, phosphoinositide-3-kinase–Akt signaling pathway, hypoxia-inducible factor 1 signaling pathway, mitogen-activated protein kinase signaling pathway and activator protein 1 signaling pathway.
first_indexed 2024-12-11T21:05:41Z
format Article
id doaj.art-9b0de782e4474098919d6899d7d0414d
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T21:05:41Z
publishDate 2019-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-9b0de782e4474098919d6899d7d0414d2022-12-22T00:50:52ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-09-011010.3389/fphar.2019.01065460863Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological InvestigationZihao Wang0Ke-Gang Linghu1Yuanjia Hu2Huali Zuo3Hao Yi4Shi-Hang Xiong5Jinjian Lu6Ging Chan7Hua Yu8Hua Yu9Hua Yu10Run-Yue Huang11Run-Yue Huang12State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, ChinaDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, ChinaHKBU Shenzhen Research Center, Shenzhen, ChinaSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong KongDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, ChinaRheumatoid arthritis is a chronic inflammatory autoimmune disease, causing articular and extra-articular dysfunctions among patients, and it could result in irreversible joint damages or disability if untreated. A traditional Chinese medicine formula, Huayu-Qiangshen-Tongbi (HT) formula, has been observed successful in controlling rheumatoid arthritis progression in traditional Chinese medicine clinics. In this study, we conducted a systematic analysis of the HT formula with a purpose of proposing for its potential mechanism of action using network pharmacological methods. The potential targets of the formula were collected and screened according to the topological features of their protein–protein interaction network, and we subsequently validated our prediction results through in vitro experiments. We proposed that the HT formula could interfere with the bone metabolism and the inflammatory pathways of the body. The experimental validation results indicated that HT formula could exhibit anti-inflammatory effects by regulating several signaling pathways specifically the Toll-like receptor signaling pathway, phosphoinositide-3-kinase–Akt signaling pathway, hypoxia-inducible factor 1 signaling pathway, mitogen-activated protein kinase signaling pathway and activator protein 1 signaling pathway.https://www.frontiersin.org/article/10.3389/fphar.2019.01065/fullrheumatoid arthritisnetwork pharmacologytraditional Chinese medicineHuayu-Qiangshen-Tongbi formulain vitro validation
spellingShingle Zihao Wang
Ke-Gang Linghu
Yuanjia Hu
Huali Zuo
Hao Yi
Shi-Hang Xiong
Jinjian Lu
Ging Chan
Hua Yu
Hua Yu
Hua Yu
Run-Yue Huang
Run-Yue Huang
Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
Frontiers in Pharmacology
rheumatoid arthritis
network pharmacology
traditional Chinese medicine
Huayu-Qiangshen-Tongbi formula
in vitro validation
title Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
title_full Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
title_fullStr Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
title_full_unstemmed Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
title_short Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
title_sort deciphering the pharmacological mechanisms of the huayu qiangshen tongbi formula through integrating network pharmacology and in vitro pharmacological investigation
topic rheumatoid arthritis
network pharmacology
traditional Chinese medicine
Huayu-Qiangshen-Tongbi formula
in vitro validation
url https://www.frontiersin.org/article/10.3389/fphar.2019.01065/full
work_keys_str_mv AT zihaowang decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT keganglinghu decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT yuanjiahu decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT hualizuo decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT haoyi decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT shihangxiong decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT jinjianlu decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT gingchan decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT huayu decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT huayu decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT huayu decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT runyuehuang decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation
AT runyuehuang decipheringthepharmacologicalmechanismsofthehuayuqiangshentongbiformulathroughintegratingnetworkpharmacologyandinvitropharmacologicalinvestigation